STANDARD LOWER DOSE (> 3 to 7.5 mg/day) vs OTHER DOSES
Leaving the study early (2‐10 weeks) vs. standard higher dose (> 7.5‐15 mg/day) · people with the acute phase of schizophrenia
It is very uncertain whether STANDARD LOWER DOSE (> 3 to 7.5 mg/day) changes leaving the study early (2‐10 weeks) vs. standard higher dose (>… compared with OTHER DOSES (very low certainty).
1 finding from 1 review
- RR 0.12 [0.01, 2.12]2 studies · 64 participantsVery low